<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>YM872, an AMPA receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, was administered together with t-PA to investigate the effects of coadministration on neuroprotection in a rat embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> model, when administered 2 h after embolism </plain></SENT>
<SENT sid="1" pm="."><plain>T-PA or YM872 alone decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and improved the neurological deficit score </plain></SENT>
<SENT sid="2" pm="."><plain>Coadministration of YM872 and t-PA resulted in a further decrease in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and improvement of the neurological score as compared with single administration of t-PA </plain></SENT>
<SENT sid="3" pm="."><plain>These data demonstrate that coadministration of YM872 and t-PA produces more potent neuroprotective effects than when t-PA is administered alone </plain></SENT>
</text></document>